CONSTELLIUM SE (CSTM) earnings date, results and what the price requires
NYSE · SEC CIK 0001563411 · SEC filings checked Oct 18, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 29, 2026 | Announced; figures arrive with the 10-Q | — | — | Filing |
| Mar 31, 2026 | Apr 29, 2026 | $2.46B | $199.0M | $1.42 | Filing |
| Dec 31, 2025 | Feb 18, 2026 | $2.20B | $112.0M | $0.79 | Filing |
| Sep 30, 2025 | Oct 29, 2025 | $2.17B | $88.0M | $0.62 | Filing |
| Jun 30, 2025 | Jul 29, 2025 | $2.10B | $36.0M | $0.25 | Filing |
| Mar 31, 2025 | Apr 30, 2025 | $1.98B | $37.0M | $0.26 | Filing |
| Dec 31, 2024 | Feb 20, 2025 | $1.72B | $-48.0M | $-0.32 | Filing |
| Sep 30, 2024 | — | $1.80B | $7.0M | $0.05 | — |
| Jun 30, 2024 | Jul 23, 2024 | $1.93B | $76.0M | $0.51 | Filing |
What would CONSTELLIUM SE have to report for its valuation to change?
At $25.47, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -6.7% a year, to $2.18. On that path the next quarter needs diluted EPS near $0.23, against $0.25 in the quarter ended Jun 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | -6.7% | -6.7% |
| EPS needed in final year | $2.18 | $2.18 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. CSTM goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.